Sales rise 11.17% to Rs 510.22 crore
Net profit of Caplin Point Laboratories rose 23.26% to Rs 152.80 crore in the quarter ended June 2025 as against Rs 123.97 crore during the previous quarter ended June 2024. Sales rose 11.17% to Rs 510.22 crore in the quarter ended June 2025 as against Rs 458.96 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales510.22458.96 11 OPM %34.8433.08 -PBDT200.75170.34 18 PBT184.46154.38 19 NP152.80123.97 23Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
